Mode
Text Size
Log in / Sign up

Patient Questions

Real questions from health communities, answered with cited research from PubMed and Vellito's article corpus. Plain language, no medical advice. How this works.

Infectious Disease

What details are available about the recent Hepatitis A outbreak in the United States?

Recent data shows a sharp rise in Hepatitis A cases across the U.S., with outbreaks linked to contaminated food, water, and specific geographic areas like Los Angeles County.

Infectious Disease

How does Hepatitis B infection prevalence differ among US adults based on their race and origin?

NHANES data show that among US adults, past or present Hepatitis B infection is more common in Black adults and those born outside the US compared to White adults or those born…

Infectious Disease

What are the new Hepatitis A immunization recommendations for the United States?

New recommendations focus on vaccinating adults at risk, including those who use drugs, are homeless, or have chronic liver disease, due to a major shift in how the virus spreads.

What role do lysosomal pathways play in the progression of autoimmune kidney disease like lupus nephritis?

Lysosomal pathways act as checkpoints that regulate immune activation, autoantigen processing, and metabolic-immune crosstalk, driving lupus nephritis progression.

Rheumatology

How does belimumab compare to anifrolumab for treating lupus nephritis?

Belimumab is approved for lupus nephritis and appears more effective than anifrolumab, which is not yet approved for this condition.

Is there a genetic variant linked to lupus nephritis risk in Chinese Han populations?

Yes, the rs80213143 variant in LOC100130476 is linked to lupus nephritis risk in Chinese Han populations, with the C allele associated with more severe kidney involvement.

Does having the CYP2C19*2 gene variant protect against cyclophosphamide side effects in lupus nephritis?

Yes, the CYP2C19*2 variant is linked to reduced cyclophosphamide toxicity in lupus nephritis, based on a meta-analysis showing a protective effect.

Do complement pathways cause kidney injuries in patients with lupus nephritis?

Yes, complement pathways — especially the classical and alternative pathways — contribute to kidney injury in lupus nephritis by driving inflammation and tissue damage after…

Does adding qiliqiangxin to my current treatment help my heart failure with reduced ejection fraction?

Yes, adding qiliqiangxin to your current treatment may reduce cardiovascular death and heart failure hospitalization in HFrEF, based on a large trial and meta-analysis.

Does Cimlanod lower the chance of dying from heart failure with reduced ejection fraction?

No, Cimlanod does not significantly lower the chance of dying from heart failure with reduced ejection fraction based on current evidence.

Will taking Cimlanod cause low blood pressure in patients with heart failure with reduced ejection fraction?

Yes, Cimlanod significantly increases the risk of low blood pressure (hypotension) in patients with heart failure with reduced ejection fraction, according to a meta-analysis.

OB/GYN & Women's Health

Does taking capecitabine or trastuzumab emtansine treat triple-negative breast cancer effectively?

Capecitabine is not a standard treatment for triple-negative breast cancer (TNBC); trastuzumab emtansine targets HER2-positive cancer, not TNBC. Neither is considered effective…

Can bacteria in my mouth change as my oral squamous cell carcinoma gets worse?

Yes, research shows that the oral microbiome, including bacteria like Veillonella, shifts as OSCC progresses, with different patterns in early vs. advanced stages.

Are there new treatments that target cell death to help oral squamous cell carcinoma?

Yes, new treatments targeting cell death pathways like ferroptosis, cuproptosis, and autophagy are being studied for oral squamous cell carcinoma, with some showing promise in…

OB/GYN & Women's Health

Does adding immune checkpoint inhibitors to chemotherapy improve survival for early-stage triple-negative breast cancer?

Yes, adding immune checkpoint inhibitors (like pembrolizumab) to chemotherapy improves event-free survival and pathologic complete response in early-stage triple-negative breast…

Oncology

Does a specific blood test score predict my survival time after oral squamous cell carcinoma?

Yes, blood test scores like COP-MPV, mGPS, NLR, and PLR are linked to survival in OSCC, but they are not precise enough to predict individual survival time.

Oncology

What are the new immunotherapy options available to improve survival for triple-negative breast cancer patients?

New immunotherapy options for triple-negative breast cancer include immune checkpoint inhibitors like pembrolizumab combined with chemotherapy, which improve survival in…

Did selective decontamination of the digestive tract show any benefit over standard care for mechanical ventilation patients?

Yes, selective decontamination of the digestive tract (SDD) likely reduces hospital mortality in mechanically ventilated ICU patients, though results vary across studies.

Which drugs work best for non-cirrhotic metabolic dysfunction-associated steatohepatitis?

For non-cirrhotic MASH, drugs targeting metabolism and insulin sensitivity (e.g., tirzepatide, semaglutide) work best, but lifestyle changes and weight loss are foundational.

Does using fewer wrist straps help adults on mechanical ventilation stay awake more often?

No, a low-use wrist-strap strategy did not improve days free of delirium or coma compared to a high-use strategy in mechanically ventilated adults.

Can machine learning diagnose metabolic dysfunction-associated steatohepatitis and fibrosis?

Yes, machine learning models show good accuracy for diagnosing MASH and fibrosis, with pooled AUROCs around 0.83-0.84, but they are not yet ready to replace liver biopsy in…

Can ultrasound of the diaphragm predict if a neurocritical patient on mechanical ventilation will breathe on their own?

Yes, diaphragm ultrasound combined with the Diaphragmatic Rapid Shallow Breathing Index (D-RSBI) can predict weaning success in neurocritical patients on mechanical ventilation…

Gastroenterology

Can lowering triglycerides help treat metabolic dysfunction-associated steatohepatitis?

Yes, lowering triglycerides may help treat MASH by reducing liver fat and improving inflammation, but more research is needed to confirm long-term benefits.

Diabetes & Endocrinology

How does brolucizumab compare to aflibercept for treating diabetic macular edema over time?

Brolucizumab and aflibercept both improve vision in diabetic macular edema, but brolucizumab may allow longer intervals between injections while carrying a higher risk of…

How this works

We pull real patient questions from public Reddit health communities (r/AskDocs, r/diabetes, r/menopause, etc.). Each question is rewritten into a generic medical question (no personal details), then answered by an AI using only cited sources from Vellito's article database and PubMed. A second AI independently scores each answer for accuracy and citation fidelity before publication. Answers below the safety threshold or touching emergency, dosing, or pediatric topics are queued for human review and never auto-published.

This is not medical advice. Always speak with your own doctor before making decisions about your health.